Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Inmune Bio (INMB) Net Cash Flow (2018 - 2025)

Inmune Bio (INMB) has disclosed Net Cash Flow for 8 consecutive years, with -$3.0 million as the latest value for Q4 2025.

  • Quarterly Net Cash Flow rose 76.93% to -$3.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $4.7 million through Dec 2025, up 130.98% year-over-year, with the annual reading at $4.0 million for FY2025, 126.32% up from the prior year.
  • Net Cash Flow hit -$3.0 million in Q4 2025 for Inmune Bio, up from -$5.6 million in the prior quarter.
  • In the past five years, Net Cash Flow ranged from a high of $45.0 million in Q3 2021 to a low of -$13.1 million in Q4 2024.
  • Historically, Net Cash Flow has averaged $1.0 million across 5 years, with a median of -$3.3 million in 2022.
  • Biggest five-year swings in Net Cash Flow: surged 2338.7% in 2021 and later crashed 774.32% in 2024.
  • Year by year, Net Cash Flow stood at -$9.8 million in 2021, then surged by 41.77% to -$5.7 million in 2022, then decreased by 3.62% to -$5.9 million in 2023, then plummeted by 121.84% to -$13.1 million in 2024, then surged by 76.93% to -$3.0 million in 2025.
  • Business Quant data shows Net Cash Flow for INMB at -$3.0 million in Q4 2025, -$5.6 million in Q3 2025, and $14.9 million in Q2 2025.